KEW Group is building a national network of community cancer care centers through a combination of acquisition and equity partnerships. The clinical and operational approach used at these centers will be based on KEW Group’s proprietary Personalized Medicine and clinical IT platforms.

Our approach is quickly scalable and operational. Thus, it is expected that it will deliver immediate benefits and attractive financial returns. The KEW Group’s founders have the demonstrated ability to execute this plan.

1. Provide outstanding clinical and patient-centered care based on a practical application of Personalized and Precision Medicine.
2. Attract and retain top clinical talent for entrepreneurial practice environments by offering the most competitive future professional opportunities.
3. Realize greater predictability, improved clinical outcomes and total costs that are 20 to 30% lower than industry standard, enabling better contracts with leading payers and self-insured employers.